Stay updated on Semaglutide Efficacy in Diabetes & Obesity Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Efficacy in Diabetes & Obesity Clinical Trial page.

Latest updates to the Semaglutide Efficacy in Diabetes & Obesity Clinical Trial page
- ChecktodayChange DetectedA site-wide notice announces NIH’s transition to using “Super Intelligence” in place of “Artificial Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check7 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1; the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check21 days agoChange DetectedThe study page now renders a 403 Forbidden error page instead of the study record, including the 403 header and the associated HTML structure. The footer/navigation area shows a Home link, signaling restricted access rather than the expected content.SummaryDifference0.5%

- Check28 days agoChange DetectedThe study page now renders a 403 Forbidden error, replacing the normal study content and navigation. Access is blocked, preventing viewing of the study's details.SummaryDifference18%

- Check35 days agoChange DetectedThe page's revision indicator was updated to v3.7.0, replacing the previous v3.6.6 in the revision history.SummaryDifference0.0%

Stay in the know with updates to Semaglutide Efficacy in Diabetes & Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Efficacy in Diabetes & Obesity Clinical Trial page.